DAIICHI SANKYO COMPANY, LIMITED
Patent Owner
Stats
- 279 US PATENTS IN FORCE
- 35 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 279 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,502 Total Citation Count
- Jun 20, 1986 Earliest Filing
- 201 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0071,403 ANTIBODY-DRUG CONJUGATE PRODUCED BY BINDING THROUGH LINKER HAVING HYDROPHILIC STRUCTURENov 22, 17Mar 15, 18[C07K]
2018/0073,084 METHOD FOR PREDICTING RESPONSIVENESS TO PHOSPHATIDYLSERINE SYNTHASE 1 INHIBITORMar 15, 16Mar 15, 18[C12Q, C12N]
2017/0296,521 PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF THROMBOEMBOLISM AFTER STENT PLACEMENTSep 01, 15Oct 19, 17[A61K]
2017/0283,885 ALGORITHMS FOR GENE SIGNATURE-BASED PREDICTOR OF SENSITIVITY TO MDM2 INHIBITORSOct 09, 15Oct 05, 17[A61K, C12Q, G01N]
2017/0260,529 POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELINGMay 24, 17Sep 14, 17[A61K, C12Q, C12N, G01N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9918938 Selective production method for D-mannitol α-form crystal using spray-drying methodSep 29, 14Mar 20, 18[A61K, C07C]
9920071 Method for producing inhibitor of activated blood coagulation factor X (FXa)Feb 13, 15Mar 20, 18[A61K, C07D]
9872924 Antibody-drug conjugate produced by binding through linker having hydrophilic structureOct 17, 13Jan 23, 18[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0114,035 Method for Manufacturing Neuraminic Acid DerivativesAbandonedJan 09, 17Apr 27, 17[C07D]
2017/0080,049 MEDICINE AGAINST GROWTH FAILURE INDUCED BY ADMINISTRATION OF STEROIDAbandonedFeb 26, 15Mar 23, 17[A61K]
2017/0022,220 HIGH-PURITY CRYSTALS OF ACTIVE BLOOD COAGULATION FACTOR X (FXA) INHIBITORAbandonedFeb 23, 15Jan 26, 17[C07D, C07C]
2016/0206,593 PHARMACEUTICAL FOR PROPHYLAXIS OR TREATMENT OF HYPERTENSIONAbandonedJan 14, 16Jul 21, 16[A61K]
2016/0137,644 METHOD FOR PRODUCING TRICYCLIC HETEROCYCLIC COMPOUNDAbandonedJun 25, 14May 19, 16[C07D, B01D]
2016/0130,663 METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENTAbandonedJul 11, 14May 12, 16[C12Q, C12N, G01N]
2016/0128,972 METHOD FOR PREVENTING INFLUENZA VIRUS INFECTION BY ADMINISTERING A DRY POWDER PHARMACEUTICAL COMPOSITIONAbandonedDec 07, 15May 12, 16[A61K]
2016/0129,008 Solid Dosage Form of Olmesartan Medoxomil and AmlodipineAbandonedJun 09, 15May 12, 16[A61K]
2016/0102,079 ACETONE SOLVATE CRYSTALS OF TRITYL OMESARTAN MEDOXOMILAbandonedOct 14, 14Apr 14, 16[C07D]
2016/0052,906 METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVESAbandonedSep 09, 15Feb 25, 16[C07D]
2015/0353,577 METHOD FOR PRODUCING (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONEAbandonedMar 28, 14Dec 10, 15[C07D, C07C]
2015/0239,909 PROCESS FOR THE PREPARATION OF (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONEAbandonedMay 13, 15Aug 27, 15[C07D, C07C]
2015/0147,326 PROTEIN BIOMARKER AND USES THEREOFAbandonedSep 30, 14May 28, 15[A61K, G01N, A61N, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
